
Oncosem is a Turkish manufacturer of fully automatic chemotherapy drug preparation systems.
oncosem.comCrawled Nov 18, 2026
Medical waste may be infectious, contain toxic chemicals, and pose contamination risks for humans and the environment.
OncoCare Smart is a fully automated chemotherapy drug preparation system meeting Class 2B2 standards.
Oncosem announced Shawky Fahim’s appointment as Middle East and Africa Regional Manager.
Oncosem displayed its products at Arab Health 2024 in Dubai from January 29 to February 1, 2024.
The company offers chemotherapy solutions, connectors, IV infusion systems, waste systems, infusion systems, and semi-finished products.
Oncosem filed its provisional tax income statement for January 1 to September 30, 2026 with the Doganbey Tax Office Directorate. The submission complies with Turkey’s Tax Procedure Law. No financial details or performance metrics are disclosed in the filing.
Oncosem achieves **19.3% revenue growth** over nine months through September 2026, alongside a **143.7% increase in operating profit** and **86% EBITDA growth**. The company also reports higher gross profit margins during the period, marking strong financial performance.
Oncosem Onkolojik Sistemler Sanayi Ve Ticaret Anonim Sirketi reports **TRY 305.84 million in third-quarter 2026 sales** and **TRY 809.91 million in nine-month 2026 sales**. The company’s financial update covers performance through September 30, 2026, reflecting its revenue growth over the period. No additional operational or strategic details are provided in the earnings release.
ONCSM.E trading was halted under an equity-based circuit breaker before resuming via a call auction session. The suspension reflects volatility triggers tied to the stock’s price movement. The company’s shares later traded through an auction process to stabilize the market.
Oncosem names Shawky Fahim as Managing Director for the Middle East & Africa region. Fahim joins to expand the company’s oncology-focused diagnostics operations in emerging markets. Oncosem specializes in liquid biopsy technologies for cancer detection.